Bencycloquidium bromide

• UNSPSC Description:

  Bencycloquidium bromide, a muscarinic M(3) receptor antagonist, is an anticholinergic compound that acts as an anticholinergic bronchodilator. Bencycloquidium bromide can be used in the study for rhinitis[1][2].

• Target Antigen:

  mAChR

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Cancer; Inflammation/Immunology; Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/bencycloquidium-bromide.html

• Solubility:

  10 mM in DMSO

• Smiles:

  C[N+]1(CC2)CCC2C(C1)OCC(C3CCCC3)(C4=CC=CC=C4)O.[Br-]

• Molecular Weight:

  410.39

• References & Citations:

  [1]Qin Xu, et al. Determination of bencycloquidium bromide in rat plasma by liquid chromatography-electrospray ionization-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 1;846(1-2):209-14.|[2]Jun-Xia Jiang, et al. Characterization of bencycloquidium bromide, a novel muscarinic M(3) receptor antagonist in guinea pig airways. Eur J Pharmacol. 2011 Mar 25;655(1-3):74-82.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Launched

• CAS Number:

  860804-18-8